title: Sequential decision strategy of the AML Cooperative Group studies.
abstract: The ongoing 1985 studies are showing at present no clear advantage for either therapy. In the 1981 study, randomization was terminated by the sequential procedure after 161 randomizations. A test with the same alpha and beta but fixed sample size would have required at least 200 patients, 100 for each therapy. So in this case the use of the sequential procedure saved about 40 randomizations.
authors.affiliation: Department of Medical Biostatistics, University of Münster, FRG.
authors.forename: A
authors.initials: A
authors.lastname: Heinecke
authors.forename: M C
authors.initials: MC
authors.lastname: Sauerland
authors.forename: T
authors.initials: T
authors.lastname: Büchner
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003659:Decision Making, Organizational; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016016:Proportional Hazards Models; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis